SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Senseonics Initiates First-in-Human Study of Freedom CGM System

Senseonics has initiated a first-in-human study of its Freedom continuous glucose monitoring system, designed to have no on-body component.

SENS

Related stories